📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Cosmos Health secures UAE market entry for supplements

EditorEmilio Ghigini
Published 03/18/2024, 09:34 AM
© Reuters.

CHICAGO - Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group, has announced its receipt of regulatory approval to sell its Sky Premium Life® vitamins and food supplements in the United Arab Emirates (UAE). The approval was granted by the Public Health & Safety Department of the Government of Dubai, issuing Consumer Product Registration Certificates valid for five years and renewable. These certificates enable the free distribution of Cosmos Health's products across the UAE.

The company has also received its initial purchase orders and is in advanced negotiations for an exclusive distribution agreement with local entities in the UAE. This strategic move taps into the growing nutrition and supplements market in the region, which, according to Insights10, is expected to reach $3.94 billion by 2030 from $1.91 billion in 2022.

Greg Siokas, CEO of Cosmos Health, expressed satisfaction with the company's market expansion efforts and the securing of regulatory approval for the entire UAE, including Dubai and Abu Dhabi. He highlighted the importance of this development in the company's goal to establish Sky Premium Life and other proprietary brands as leaders in the global market.

Cosmos Health, based in Chicago and incorporated in 2009, is engaged in a range of healthcare activities. These include owning a portfolio of pharmaceutical and nutraceutical brands, manufacturing under European Good Manufacturing Practices (GMP), and operating a telehealth platform through its acquisition of ZipDoctor, Inc. The company's expansion strategy focuses on growing its presence in Europe, Asia, and North America.

The information in this article is based on a press release statement and provides an overview of Cosmos Health's recent regulatory achievements and business aspirations in the UAE market. The company's progress reflects its broader objectives of increasing brand awareness and revenue through international market penetration.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.